Pfizer Names New Global Supply Chief As Frank D'Amelio Steps Down from CFO Position

Pfizer Inc. (PFE), the global pharmaceutical and biotechnology leader, announced the appointment of Mike McDermott as Executive Vice President and Chief Global Supply Officer, effective January 1, 2022. McDermott’s promotion marks a strategic leadership realignment as the company simultaneously confirms the planned retirement of Frank D’Amelio from his dual role as Chief Financial Officer and Executive Vice President of Global Supply.

McDermott brings nearly two decades of operational expertise to the expanded role. Since joining Pfizer in 2003, he has progressed through increasingly senior positions within the organization’s supply chain operations. Most recently serving as President of Pfizer Global Supply since 2019, McDermott previously led biotech manufacturing operations at the company’s Pearl River, New York facility when it was part of Wyeth’s operations portfolio. His career trajectory reflects a deep understanding of Pfizer’s complex manufacturing and distribution infrastructure.

The transition of Frank D’Amelio’s responsibilities represents a significant organizational shift for the pharmaceutical giant. While D’Amelio departs from his executive roles, Pfizer has arranged for him to remain available during the leadership handover period, offering consulting support to ensure continuity. Concurrently, the company has initiated an external recruitment process to identify and appoint a new Chief Financial Officer, with D’Amelio’s consulting engagement extending through the completion of this search.

This executive reorganization underscores Pfizer’s commitment to strengthening its operational and financial leadership structure as the company navigates ongoing market dynamics in the pharmaceutical sector.